662 research outputs found
Impact of Terminology Mapping on Population Health Cohorts IMPaCt
Background and Objectives: The population health care delivery model uses phenotype algorithms in the electronic health record (EHR) system to identify patient cohorts targeted for clinical interventions such as laboratory tests, and procedures. The standard terminology used to identify disease cohorts may contribute to significant variation in error rates for patient inclusion or exclusion. The United States requires EHR systems to support two diagnosis terminologies, the International Classification of Disease (ICD) and the Systematized Nomenclature of Medicine (SNOMED). Terminology mapping enables the retrieval of diagnosis data using either terminology. There are no standards of practice by which to evaluate and report the operational characteristics of ICD and SNOMED value sets used to select patient groups for population health interventions. Establishing a best practice for terminology selection is a step forward in ensuring that the right patients receive the right intervention at the right time. The research question is, âHow does the diagnosis retrieval terminology (ICD vs SNOMED) and terminology map maintenance impact population health cohorts?â Aim 1 and 2 explore this question, and Aim 3 informs practice and policy for population health programs.
Methods
Aim 1: Quantify impact of terminology choice (ICD vs SNOMED)
ICD and SNOMED phenotype algorithms for diabetes, chronic kidney disease (CKD), and heart failure were developed using matched sets of codes from the Value Set Authority Center. The performance of the diagnosis-only phenotypes was compared to published reference standard that included diagnosis codes, laboratory results, procedures, and medications.
Aim 2: Measure terminology maintenance impact on SNOMED cohorts
For each disease state, the performance of a single SNOMED algorithm before and after terminology updates was evaluated in comparison to a reference standard to identify and quantify cohort changes introduced by terminology maintenance.
Aim 3: Recommend methods for improving population health interventions
The socio-technical model for studying health information technology was used to inform best practice for the use of population health interventions.
Results
Aim 1: ICD-10 value sets had better sensitivity than SNOMED for diabetes (.829, .662) and CKD (.242, .225) (N=201,713, p
Aim 2: Following terminology maintenance the SNOMED algorithm for diabetes increased in sensitivity from (.662 to .683 (p
Aim 3: Based on observed social and technical challenges to population health programs, including and in addition to the development and measurement of phenotypes, a practical method was proposed for population health intervention development and reporting
Time-dependent metabolic phenotyping of inflammatory dysregulation
A rich and functional description of a patient health status is the fundamental basis for the personalisation of treatment and the targeting of interventions. The function of inflammation in the healing process as well as its involvement in most major diseases is well established, yet the specific mechanism by which it contributes to the pathogenesis is still not fully understood. If conditions arising from a dysregulation of the inflammatory process are to be treated before they become irreversible, a novel understanding of these pathologies must be achieved and a stratification of patients based on their inflammatory status undertaken.
The work presented in this thesis aims to deliver new analytical and statistical approaches to support the investigation of the time-dependent dysregulation of inflammation.
Lipid mediators have been described as exerting a major role in the initiation and regulation of the inflammatory response, yet analytical platforms for their large-scale characterisation in human biofluids are lacking. This thesis reports the validation of an assay for the simultaneous quantification of pro- and anti-inflammatory signalling molecules in multiple human biofluids. The coverage of the assay in each biofluid is subsequently established, characterising inflammatory signalling across biological compartments. A second study explores the assayâs applicability in a clinical context; investigating the relationship between lipid mediators, current clinical markers of inflammation and post-operative complications.
Characterising the interplay between signalling and regulatory networks is key to understanding a living systemâs response to perturbations, yet few statistical approaches are suited for the detection of time-dependent patterns in short and irregularly sampled longitudinal datasets. This thesis reports the development of a statistical approach to support the identification of altered time-trajectories in such studies. The methodâs wide applicability is subsequently demonstrated on two investigations covering the diversity of metabolic phenotyping data generation platforms.
This thesis is a proof of concept for the characterisation of patient-specific inflammatory status in a clinical context and the identification of altered time-dependent patterns. Both analytical and statistical developments have been motivated by the needs of real world applications and provide a template for the characterisation and analysis of the molecular basis for treatment.Open Acces
Optimized identification of advanced chronic kidney disease and absence of kidney disease by combining different electronic health data resources and by applying machine learning strategies
Automated identification of advanced chronic kidney disease (CKD â„ III) and of no known kidney disease (NKD) can support both clinicians and researchers. We hypothesized that identification of CKD and NKD can be improved, by combining information from different electronic health record (EHR) resources, comprising laboratory values, discharge summaries and ICD-10 billing codes, compared to using each component alone. We included EHRs from 785 elderly multimorbid patients, hospitalized between 2010 and 2015, that were divided into a training and a test (n = 156) dataset. We used both the area under the receiver operating characteristic (AUROC) and under the precision-recall curve (AUCPR) with a 95% confidence interval for evaluation of different classification models. In the test dataset, the combination of EHR components as a simple classifier identified CKD â„ III (AUROC 0.96[0.93â0.98]) and NKD (AUROC 0.94[0.91â0.97]) better than laboratory values (AUROC CKD 0.85[0.79â0.90], NKD 0.91[0.87â0.94]), discharge summaries (AUROC CKD 0.87[0.82â0.92], NKD 0.84[0.79â0.89]) or ICD-10 billing codes (AUROC CKD 0.85[0.80â0.91], NKD 0.77[0.72â0.83]) alone. Logistic regression and machine learning models improved recognition of CKD â„ III compared to the simple classifier if only laboratory values were used (AUROC 0.96[0.92â0.99] vs. 0.86[0.81â0.91], p < 0.05) and improved recognition of NKD if information from previous hospital stays was used (AUROC 0.99[0.98â1.00] vs. 0.95[0.92â0.97]], p < 0.05). Depending on the availability of data, correct automated identification of CKD â„ III and NKD from EHRs can be improved by generating classification models based on the combination of different EHR components
Recommended from our members
Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
Through the measure of thousands of small-molecule metabolites in diverse biological systems, metabolomics now offers the potential for new insights into the factors that contribute to complex human diseases such as cardiovascular disease. Targeted metabolomics methods have already identified new molecular markers and metabolomic signatures of cardiovascular disease risk (including branched-chain amino acids, select unsaturated lipid species, and trimethylamine-N-oxide), thus in effect linking diverse exposures such as those from dietary intake and the microbiota with cardiometabolic traits. As technologies for metabolomics continue to evolve, the depth and breadth of small-molecule metabolite profiling in complex systems continue to advance rapidly, along with prospects for ongoing discovery. Current challenges facing the field of metabolomics include scaling throughput and technical capacity for metabolomics approaches, bioinformatic and chemoinformatic tools for handling large-scale metabolomics data, methods for elucidating the biochemical structure and function of novel metabolites, and strategies for determining the true clinical relevance of metabolites observed in association with cardiovascular disease outcomes. Progress made in addressing these challenges will allow metabolomics the potential to substantially affect diagnostics and therapeutics in cardiovascular medicine
Recommended from our members
Generating Reliable and Responsive Observational Evidence: Reducing Pre-analysis Bias
A growing body of evidence generated from observational data has demonstrated the potential to influence decision-making and improve patient outcomes. For observational evidence to be actionable, however, it must be generated reliably and in a timely manner. Large distributed observational data networks enable research on diverse patient populations at scale and develop new sound methods to improve reproducibility and robustness of real-world evidence. Nevertheless, the problems of generalizability, portability and scalability persist and compound. As analytical methods only partially address bias, reliable observational research (especially in networks) must address the bias at the design stage (i.e., pre-analysis bias) including the strategies for identifying patients of interest and defining comparators.
This thesis synthesizes and enumerates a set of challenges to addressing pre-analysis bias in observational studies and presents mixed-methods approaches and informatics solutions for overcoming a number of those obstacles. We develop frameworks, methods and tools for scalable and reliable phenotyping including data source granularity estimation, comprehensive concept set selection, index date specification, and structured data-based patient review for phenotype evaluation. We cover the research on potential bias in the unexposed comparator definition including systematic background rates estimation and interpretation, and definition and evaluation of the unexposed comparator.
We propose that the use of standardized approaches and methods as described in this thesis not only improves reliability but also increases responsiveness of observational evidence. To test this hypothesis, we designed and piloted a Data Consult Service - a service that generates new on-demand evidence at the bedside. We demonstrate that it is feasible to generate reliable evidence to address cliniciansâ information needs in a robust and timely fashion and provide our analysis of the current limitations and future steps needed to scale such a service
Autoantibodies to N-terminally Truncated GAD(65)(96-585) : HLA Associations and Predictive Value for Type 1 Diabetes
Objective To evaluate the role of autoantibodies to N-terminally truncated glutamic acid decarboxylase GAD(65)(96-585) (t-GADA) as a marker for type 1 diabetes (T1D) and to assess the potential human leukocyte antigen (HLA) associations with such autoantibodies. Design In this cross-sectional study combining data from the Finnish Pediatric Diabetes Register, the Type 1 Diabetes Prediction and Prevention study, the DIABIMMUNE study, and the Early Dietary Intervention and Later Signs of Beta-Cell Autoimmunity study, venous blood samples from 760 individuals (53.7% males) were analyzed for t-GADA, autoantibodies to full-length GAD(65) (f-GADA), and islet cell antibodies. Epitope-specific GAD autoantibodies were analyzed from 189 study participants. Results T1D had been diagnosed in 174 (23%) participants. Altogether 631 (83%) individuals tested positive for f-GADA and 451 (59%) for t-GADA at a median age of 9.0 (range 0.2-61.5) years. t-GADA demonstrated higher specificity (46%) and positive predictive value (30%) for T1D than positivity for f-GADA alone (15% and 21%, respectively). Among participants positive for f-GADA, those who tested positive for t-GADA carried more frequently HLA genotypes conferring increased risk for T1D than those who tested negative for t-GADA (77% vs 53%; P < 0.001). Conclusions Autoantibodies to N-terminally truncated GAD improve the screening for T1D compared to f-GADA and may facilitate the selection of participants for clinical trials. HLA class II-mediated antigen presentation of GAD(96-585)-derived or structurally similar peptides might comprise an important pathomechanism in T1D.Peer reviewe
Recommended from our members
Electronic Health Record Summarization over Heterogeneous and Irregularly Sampled Clinical Data
The increasing adoption of electronic health records (EHRs) has led to an unprecedented amount of patient health information stored in an electronic format. The ability to comb through this information is imperative, both for patient care and computational modeling. Creating a system to minimize unnecessary EHR data, automatically distill longitudinal patient information, and highlight salient parts of a patientâs record is currently an unmet need. However, summarization of EHR data is not a trivial task, as there exist many challenges with reasoning over this data. EHR data elements are most often obtained at irregular intervals as patients are more likely to receive medical care when they are ill, than when they are healthy. The presence of narrative documentation adds another layer of complexity as the notes are riddled with over-sampled text, often caused by the frequent copy-and-pasting during the documentation process.
This dissertation synthesizes a set of challenges for automated EHR summarization identified in the literature and presents an array of methods for dealing with some of these challenges. We used hybrid data-driven and knowledge-based approaches to examine abundant redundancy in clinical narrative text, a data-driven approach to identify and mitigate biases in laboratory testing patterns with implications for using clinical data for research, and a probabilistic modeling approach to automatically summarize patient records and learn computational models of disease with heterogeneous data types. The dissertation also demonstrates two applications of the developed methods to important clinical questions: the questions of laboratory test overutilization and cohort selection from EHR data
Exploring gut microbiome â host interactions in the extremes of health and disease
Introduction: Multi âomics analyses, including metabonomic and metagenomic profiling techniques, have enabled new insights into systems biology over the past decade. Using two extremes of a continuum between health and disease â elite athletes and obese patients undergoing bariatric surgery â the work in this thesis aims to apply metabolic phenotyping to further understand the impact of exercise, diet and obesity on human metabolism. Furthermore, through combinatorial analysis of metabonomic and gut microbiome data sets, host â gut microbiome co-metabolism and its influence on health is explored in these two extreme populations.
Methods: Biofluids were collected from three cohorts: i) elite athletes and age and sex matched controls, ii) healthy individuals before and after a high protein diet, exercise regime or both, and iii) obese subjects pre and post bariatric surgery. Multiple analytical platforms were utilised for metabolic profiling including 1H-NMR spectroscopy, UPLC-MS and GC-MS. Gut microbiome analysis was performed using next generation metagenomic sequencing. After pre-processing the metabonomic and metagenomic data; univariate, unsupervised and supervised multivariate analyses were performed as well as gut microbiome-metabolite association studies.
Results: Distinct metabolic and microbial phenotypes existed between both athletes and controls and between obese patients before and after bariatric surgery. Discriminatory metabolites higher in athletes include metabolites associated with muscle turnover, vitamins and recovery supplements, a high protein diet and those derived from gut microbes. Interestingly, increased bacterial diversity seen in athletes correlated with a specific subset of metabolites. Similarly, bariatric surgery resulted in large changes to circulating metabolites. A number of these metabolites were linked to changes in the gut microbiome, including bile acids, short-chain fatty acids and amino acids.
Conclusion: This thesis extends existing knowledge of the gut microbiomeâs influence on human health through small molecule signalling. Mechanistic studies are now needed to establish causal links between gut microbes, changes to circulating metabolites and disease status.Open Acces
- âŠ